Position Paper on the Critical Medicines Act (CMA)

Medicines for Europe note on Bio Innovation list of substances found in urban wastewater

Medicines for Europe Trade Recommendations – Strengthening Global Access to Medicines

Medicines for Europe Critical Medicines Act Initial Assessment

New Attempt to Introduce Unlawful-Patent Linkage in Bolar

Medicines for Europe response to the Strategy for European Life Sciences

The Urban Waste Water Treatment Directive (UWWTD) must be simplified via the EU omnibus or essential medicines will no longer be available for patients in Europe

5-Point Pharmaceutical Action Plan to Sustain Investment in Europe, for Europe

Note on Proposals to Extend Pharmaceutical Intellectual Property Incentives in reaction to U.S. Tariffs

The Severe Impacts of Potential U.S. Tariffs on Pharmaceuticals